• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Increased prevalence of anxiety symptoms modestly associated with poor air quality

byDaniel FisherandRavi Shah
April 2, 2015
in Chronic Disease, Public Health
Reading Time: 3 mins read
Autism associated with air pollution exposure during pregnancy
Share on FacebookShare on TwitterShare on LinkedIn

1. Greater and more recent exposure to fine particulate matter, was linked with a small increase in anxiety symptom risk.

2. No association was found between anxiety symptom risk and coarse particulate matter or proximity to major roadways.

Evidence Rating Level: 2 (Good)

Study Rundown: The risk of developing mental illness is highly dependent on genetic predispositions and adverse environments. While the presence of fine particulate matter (2.5 micrometers or less, PM2.5) has already been linked with increased risk of cardiovascular disease, little is still known about the risk of particulate matter exposure and mental illness. This observational cohort study, using data from the Nurses’ Health Study, found an increased risk of anxiety with increased exposure to PM2.5, but not PM2.5-10, through a spatiotemporal prediction model. The relative contribution of PM2.5 to increased anxiety symptom risk was observed at time windows of 1 month to 15 years and was roughly around 10-15% in increased risk. There no change in this correlation when considering age, previous anxiety levels before the study period, proximity to a major roadway, region of the country, presence of co-morbidities including pulmonary and cardiac disease, and high levels of coarse particulate matter.

The results of this study are intriguing and lend support to a growing body of evidence linking systemic inflammation with increased risk of mental illness. However, the small effect size in this study, spatiotemporal prediction as opposed to direct measurement of PM2.5, and lack of clinical diagnosis of anxiety/depression should warrant a conservative interpretation of these findings, as a mechanistic understanding of this association is far from clear. A future prospective cohort study analyzing anxiety symptoms and PM2.5 with timed blood draws to measure inflammatory markers in parallel may greatly increase our understanding of this process and help validate this study’s results.

Click to read the study in the BMJ

RELATED REPORTS

Children with intellectual and developmental disabilities have increased risks of depression and anxiety

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

Click to read an accompanying editorial in the BMJ

Relevant Reading: Effect of long-term outdoor air pollution and noise on cognitive and psychological function in adults

In-Depth [retrospective cohort]: 71,271 women (age 57-85) originally participants of the Nurse’s Health Study in the United States were surveyed to elucidate the relationship between pollution and anxiety. Spatiotemporal predictions of particulate matter pollution were compiled using geographic, meteorological, and nationwide monitor data and prevalence of anxiety symptoms was measured by the Crown-Crisp phobic anxiety scale score (not an official diagnosis of anxiety). The adjusted odds ratios per 10 μg/m3 greater exposure to PM2.5 and high levels of anxiety symptoms were 1.12 (CI95 1.06-1.19) for the 1 month time window post exposure, 1.13 (CI95 1.06-1.21) for 3 months, 1.14 (CI95 1.05-1.23) for 6 months, 1.15 (CI95 1.06-1.23) for 12 months, and 1.09 (CI95 1.01-1.18) for 15 years. There were no changes in these associations when considering age, previous anxiety levels before the study period, proximity to a major roadway, region of the country, presence of co-morbidities including pulmonary and cardiac disease, and high levels of coarse particulate matter, among a comprehensive list of potential confounders. There was no association found between exposure to PM2.5-10 and high anxiety symptoms.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anxiety
Previous Post

Hyperkalemia rare among healthy women taking spironolactone for acne

Next Post

Exposure to air pollution linked to increased risk of stroke

RelatedReports

A young boy studying at a desk with books and a contrasting image of an adult man walking outdoors, symbolizing the life course from childhood to adulthood.
Pediatrics

Children with intellectual and developmental disabilities have increased risks of depression and anxiety

October 14, 2026
A man sits pensively by a window with a depiction of a synapse illustrating neurotransmitter activity, suggesting a focus on mental health treatment mechanisms.
Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Chronic Disease

Patient and provider characteristics associated with difficult clinical encounters

January 12, 2026
2 Minute Medicine Rewind March 4, 2019
Chronic Disease

Notification of breast density is associated with increased anxiety and confusion

January 13, 2026
Next Post
Stroke expansion following intra-arterial therapy may explain worse outcomes

Exposure to air pollution linked to increased risk of stroke

Polyethylene glycol superior to lactulose for hepatic encephalopathy [HELP trial]

Sofosbuvir therapy may be cost-effective for certain hepatitis C patients

Reperfusion therapy may be suboptimal for STEMIs requiring transfers

Intra-aortic balloon pumps do not improve mortality after severe acute myocardial infarctions

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An electronic health record tool for exercise prescription may reduce fall rate among older adults
  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.